Table II.
3.5% dextran sulfate sodium | ||||||
---|---|---|---|---|---|---|
Gl, g/kg | ||||||
Variable | Control | Model | Sulfasalazine, 0.6 g/kg | 1.0 | 2.0 | 4.0 |
Body weight, g | ||||||
Day 1 | 22.8±0.2 | 22.6±0.4 | 22.3±0.4 | 22.5±0.3 | 22.6±0.4 | 22.6±0.3 |
Day 7 | 22.4±0.3 | 20.3±0.3a | 20.2±0.3 | 20.5±0.4 | 20.3±0.3 | 20.5±0.3 |
Day 14 | 24.4±0.3 | 20.6±0.8b | 21.2±0.5 | 21.4±0.7 | 21.6±0.3 | 21.2±0.7 |
Day 21 | 25.4±0.4 | 20.8±0.8b | 22.1±0.4 | 22.3±0.5 | 22.9±0.3d | 22.0±0.5 |
Day 28 | 24.3±0.4 | 21.2±0.5b | 22.1±0.3 | 22.7±0.5d | 23.4±0.3d | 21.5±0.3 |
Organ index, % | ||||||
Spleen | 0.25±0.05 | 0.56±0.10c | 0.45±0.05d | 0.49±0.14 | 0.44±0.10d | 0.38±0.11e |
Liver | 3.72±0.31 | 4.34±0.24a | 4.32±0.13 | 3.95±0.44d | 3.79±0.40d | 3.58±0.27e |
Kidney | 1.16±0.05 | 1.03±0.05a | 1.13±0.06d | 1.10±0.10 | 1.11±0.05d | 1.01±0.07 |
Data were analyzed using a one-way ANOVA and are expressed as mean ± SEM (n=8).
P<0.05
P<0.01
P<0.001 vs. control mice
P<0.05
P<0.01 vs. DSS-induced UC mice. GI, Gloeostereum incarnatum.